English
 
Help Privacy Policy Disclaimer
  Advanced SearchBrowse

Item

ITEM ACTIONSEXPORT
  CD74-NRG1 fusions are oncogenic in vivo and induce therapeutically tractable ERBB2:ERBB3 heterodimerization

Werr, L., Plenker, D., Dammert, M. A., Lorenz, C., Bragelmann, J., Tumbrink, H. L., et al. (2022). CD74-NRG1 fusions are oncogenic in vivo and induce therapeutically tractable ERBB2:ERBB3 heterodimerization. Molecular Cancer Therapeutics, 21(5), 821-830. doi:10.1158/1535-7163.MCT-21-0820.

Item is

Basic

show hide
Genre: Journal Article

Files

show Files

Locators

show

Creators

show
hide
 Creators:
Werr, Lisa, Author
Plenker, Dennis, Author
Dammert, Marcel A., Author
Lorenz, Carina, Author
Bragelmann, Johannes, Author
Tumbrink, Hannah L., Author
Klein, Sebastian, Author
Schmitt, Anna, Author
Buttner, Reinhard, Author
Persigehl, Thorsten, Author
Shokat, Kevan M., Author
Wunderlich, Frank Thomas1, Author              
Schram, Alison M., Author
Peifer, Martin2, Author              
Sos, Martin L.2, Author              
Reinhardt, Hans Christian3, Author              
Thomas, Roman K.2, Author              
Affiliations:
1Obesity and Cancer, Department Jens Brüning, Max Planck Institute for Metabolism Research, Managing Director: Jens Brüning, Max Planck Society, ou_2149645              
2Funktionelle Krebsgenomforschung, Junior Research Groups, Max-Planck-Institut für neurologische Forschung, Managing Director: D. Yves von Cramon, Max Planck Institute for Metabolism Research, Managing Director: Jens Brüning, Max Planck Society, ou_2149656              
3Neuronal Control of Metabolism, Department Jens Brüning, Max Planck Institute for Metabolism Research, Managing Director: Jens Brüning, Max Planck Society, ou_2149644              

Content

show

Details

show
hide
Language(s): eng - English
 Dates: 2022
 Publication Status: Published in print
 Pages: -
 Publishing info: -
 Table of Contents: -
 Rev. Type: Peer
 Identifiers: DOI: 10.1158/1535-7163.MCT-21-0820
 Degree: -

Event

show

Legal Case

show

Project information

show

Source 1

show
hide
Title: Molecular Cancer Therapeutics
  Other : Mol. Cancer Ther.
Source Genre: Journal
 Creator(s):
Affiliations:
Publ. Info: Philadelphia, PA : American Association for Cancer Research, Inc.
Pages: - Volume / Issue: 21 (5) Sequence Number: - Start / End Page: 821 - 830 Identifier: ISSN: 1535-7163
CoNE: https://pure.mpg.de/cone/journals/resource/111022849554084